Dendreon Corp (NASDAQ:DNDN)

CAPS Rating: 2 out of 5

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.

Recs

0
Player Avatar Bearywhite (< 20) Submitted: 8/4/2011 9:04:49 PM : Outperform Start Price: $12.20 DNDN Score: -51.41

Short term gains as the panic levels

Report this Post Reply

Featured Broker Partners


Advertisement